Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05131867Phase 2Completed
A Phase 2 trial of milrinone in cerebral vasospasm, sponsored by Zagazig University. Started Nov 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05131867.